About this document
Piramal Pharma Q3 FY25 Earnings Call Summary by x5njnqkw9d is a document available to read on EtoBox.
- Author
- x5njnqkw9d
- Language
- EN
About this book
Piramal Pharma Limited reported a 14% revenue growth and a 20% EBITDA increase for the first nine months of FY
Details
Rate this book
Sign in to rate this book
Quick info
- Language
- en
- Availability
- Checking…